Search
Descriptor English: Lidoflazine
Descriptor Spanish: Lidoflazina
Descriptor lidoflacina
Entry term(s) lidoflazina
Scope note: Vasodilatador coronario con alguna acción antiarrítmica.
Descriptor Portuguese: Lidoflazina
Descriptor French: Lidoflazine
Entry term(s): Clinium
Ordiflazine
Tree number(s): D03.383.606.596
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D008013
Scope note: Coronary vasodilator with some antiarrhythmic action.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Calcium Channel Blockers
Bloqueadores de los Canales de Calcio
Bloqueadores dos Canais de Cálcio
Inhibiteurs des canaux calciques
bloqueantes de los canales del calcio
Vasodilator Agents
Vasodilatadores
Vasodilatadores
Vasodilatateurs
vasodilatadores
Registry Number: J4ZHN3HBTE
CAS Type 1 Name: 1-Piperazineacetamide, 4-(4,4-bis(4-fluorophenyl)butyl)-N-(2,6-dimethylphenyl)-
Previous Indexing: Acetic Acids (1966-1972)
Amides (1966-1972)
Piperazines (1966-1972)
Xylenes (1966-1972)
Public MeSH Note: 91; was see under PIPERAZINES 1973-90
History Note: 91(73); was see under PIPERAZINES 1973-90
DeCS ID: 8189
Unique ID: D008013
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/05/31
Lidoflazine - Preferred
Concept UI M0012491
Scope note Coronary vasodilator with some antiarrhythmic action.
Preferred term Lidoflazine
Clinium - Narrower
Concept UI M0353371
Preferred term Clinium
Ordiflazine - Narrower
Concept UI M0353372
Preferred term Ordiflazine



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey